Norelgestromin and Ethinly Estradiol
Norelgestromin and Ethinly Estradiol is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Norelgestromin and Ethinly Estradiol. Available dosage form: patch.
Drug Details
- Generic Name
- Norelgestromin and Ethinly Estradiol
- Brand Names
- Norelgestromin and Ethinly Estradiol
- Application Number
- ANDA213950
- Sponsor
- Amneal Pharmaceuticals NY LLC
- NDC Codes
- 1
- Dosage Forms
- PATCH
- Routes
- TRANSDERMAL
- Active Ingredients
- NORELGESTROMIN, ETHINYL ESTRADIOL
Indications and Usage
1 INDICATIONS AND USAGE Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. Limitations of Use : Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women who weigh 198 lbs (90 kg) or more. Norelgestromin and ethinyl estradiol transdermal system is contraindicated for use in women with BMI ≥ 30 kg/m 2 [see Contraindications (4) , Warnings and Precautions (5.1) and Clinical Studies (14) ] . Norelgestromin and ethinyl estradiol transdermal system is an estrogen/progestin combination hormonal contraceptive (CHC), indicated for the prevention of pregnancy in women with a BMI < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. ( 1 ) Limitations of Use : Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women at or above 198 lbs (90 kg). ( 1 , 4 , 14 )